Ryan Cinalli, PhD,
Chief Scientific Officer
Ryan has over 15 years of experience in the life sciences as an investment banker, research analyst and research scientist. Prior to joining LifeSci Partners in 2018, Ryan served as a member of the healthcare investment banking team at MTS Health Partners, where he advised leading biopharma companies on strategic and equity financing engagements. Prior to MTS, he was a research analyst at LifeSci Capital where he covered oncology, immunology and inflammation. Previously, he was a research scientist at Penn, NYU and Mount Sinai, where he worked with world class academic scientists, including Craig B. Thompson, Ruth Lehmann and Philippe Soriano, to identify novel therapeutic targets for oncology and regenerative medicine. His work has been presented at major medical meetings and published in leading scientific journals, including Cell, Science and Nature.
Ryan holds an B.S. in Biochemistry from Stockton College and completed his Ph.D. research in a Howard Hughes laboratory at the NYU School of Medicine, where he was awarded an NSF Graduate Research Fellowship for his work.